• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症中胶质细胞谷氨酸转运体GLT-1的选择性缺失。

Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

作者信息

Rothstein J D, Van Kammen M, Levey A I, Martin L J, Kuncl R W

机构信息

Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.

出版信息

Ann Neurol. 1995 Jul;38(1):73-84. doi: 10.1002/ana.410380114.

DOI:10.1002/ana.410380114
PMID:7611729
Abstract

The pathogenesis of sporadic amyotrophic lateral sclerosis (ALS) is unknown, but defects in synaptosomal high-affinity glutamate transport have been observed. In experimental models, chronic loss of glutamate transport can produce a loss of motor neurons and, therefore, could contribute to the disease. With the recent cloning of three glutamate transporters, i.e., EAAC1, GLT-1, and GLAST, it has become possible to determine if the loss of glutamate transport in ALS is subtype specific. We developed C-terminal, antioligopeptide antibodies that were specific for each glutamate transporter. EAAC1 is selective for neurons, while GLT-1 and GLAST are selective for astroglia. Tissue from various brain regions of ALS patients and controls were examined by immunoblot or immunocytochemical methods for each transporter subtype. All tissue was matched for age and postmortem delay. GLT-1 immunoreactive protein was severely decreased in ALS, both in motor cortex (71% decrease compared with control) and in spinal cord. In approximately a quarter of the ALS motor cortex specimens, the loss of GLT-1 protein (90% decrease from control) was dramatic. By contrast, there was only a modest loss (20% decrease from control) of immunoreactive protein EAAC1 in ALS motor cortex, and there was no appreciable change in GLAST. The minor loss of EAAC1 could be secondary to loss of cortical motor neurons. As a comparison, glial fibrillary acidic protein, which is selectively localized to astroglia, was not changed in ALS motor cortex. Because there is no loss of astroglia in ALS, the dramatic abnormalities in GLT-1 could reflect a primary defect in GLT-1 protein, a secondary loss due to down regulation, or other toxic processes.

摘要

散发性肌萎缩侧索硬化症(ALS)的发病机制尚不清楚,但已观察到突触体高亲和力谷氨酸转运存在缺陷。在实验模型中,谷氨酸转运的长期丧失可导致运动神经元丧失,因此可能与该疾病有关。随着最近三种谷氨酸转运体即EAAC1、GLT-1和GLAST的克隆成功,确定ALS中谷氨酸转运丧失是否具有亚型特异性成为可能。我们开发了对每种谷氨酸转运体具有特异性的C末端抗寡肽抗体。EAAC1对神经元具有选择性,而GLT-1和GLAST对星形胶质细胞具有选择性。通过免疫印迹或免疫细胞化学方法对ALS患者和对照的不同脑区组织进行每种转运体亚型的检测。所有组织在年龄和死后延迟方面进行匹配。在ALS患者中,运动皮层(与对照相比减少71%)和脊髓中的GLT-1免疫反应性蛋白均严重减少。在大约四分之一的ALS运动皮层标本中,GLT-1蛋白的丧失(比对照减少90%)非常显著。相比之下,ALS运动皮层中免疫反应性蛋白EAAC1仅有适度丧失(比对照减少20%),而GLAST没有明显变化。EAAC1的轻微丧失可能继发于皮层运动神经元的丧失。作为比较,选择性定位于星形胶质细胞的胶质纤维酸性蛋白在ALS运动皮层中没有变化。由于ALS中星形胶质细胞没有丧失,GLT-1的显著异常可能反映GLT-1蛋白的原发性缺陷、下调导致的继发性丧失或其他毒性过程。

相似文献

1
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中胶质细胞谷氨酸转运体GLT-1的选择性缺失。
Ann Neurol. 1995 Jul;38(1):73-84. doi: 10.1002/ana.410380114.
2
Differential abundance of glutamate transporter subtypes in amyotrophic lateral sclerosis (ALS)-vulnerable versus ALS-resistant brain stem motor cell groups.肌萎缩侧索硬化症(ALS)易损与抗ALS脑干运动细胞群中谷氨酸转运体亚型的差异丰度。
Exp Neurol. 1996 Dec;142(2):287-95. doi: 10.1006/exnr.1996.0198.
3
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).在家族性肌萎缩侧索硬化症(ALS)细胞模型中,GLT-1胶质谷氨酸转运体的内化和降解增加。
J Cell Sci. 2004 Oct 15;117(Pt 22):5417-26. doi: 10.1242/jcs.01411. Epub 2004 Oct 5.
4
GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.在表达G93A人突变型超氧化物歧化酶1(SOD1)的小鼠中,谷氨酸转运体-1(GLT-1)水平未发生变化。
J Neurol Sci. 2002 Jan 15;193(2):117-26. doi: 10.1016/s0022-510x(01)00656-6.
5
Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.转基因超氧化物歧化酶1 G93A小鼠脊髓中谷氨酸转运体-1水平降低,但脑脊液谷氨酸水平无变化。
J Neurochem. 2001 Nov;79(4):737-46. doi: 10.1046/j.1471-4159.2001.00572.x.
6
Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex.肌萎缩侧索硬化症运动皮层中谷氨酸转运体基因的表达
Ann Neurol. 1996 May;39(5):676-9. doi: 10.1002/ana.410390519.
7
Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat.大鼠控制性皮质撞击伤后分支状小胶质细胞中谷氨酸转运蛋白的早期表达
Glia. 2001 Sep;35(3):167-79. doi: 10.1002/glia.1082.
8
Neuronal regulation of glutamate transporter subtype expression in astrocytes.星形胶质细胞中谷氨酸转运体亚型表达的神经元调节。
J Neurosci. 1997 Feb 1;17(3):932-40. doi: 10.1523/JNEUROSCI.17-03-00932.1997.
9
Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.肌萎缩侧索硬化中的兴奋毒性与神经退行性变
Clin Neurosci. 1995;3(6):348-59.
10
Modulation of glutamate transporters (GLAST, GLT-1 and EAAC1) in the rat cerebellum following portocaval anastomosis.门腔静脉吻合术后大鼠小脑谷氨酸转运体(GLAST、GLT-1和EAAC1)的调节
Brain Res. 2000 Mar 24;859(2):293-302. doi: 10.1016/s0006-8993(00)01993-4.

引用本文的文献

1
An unrecognized mechanism of self-protection in degenerating neurons mediated by astrocytic YAP through Wnts/β-catenin/EAAT2 signaling in C9orf72-poly-GA mice.在C9orf72-多聚-GA小鼠中,星形胶质细胞YAP通过Wnts/β-连环蛋白/EAAT2信号介导的退化神经元自我保护的一种未被识别的机制。
Theranostics. 2025 Jul 24;15(16):8176-8201. doi: 10.7150/thno.113599. eCollection 2025.
2
NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies.神经退行性疾病中的N-甲基-D-天冬氨酸受体:机制与新兴治疗策略
Front Aging Neurosci. 2025 Jul 24;17:1604378. doi: 10.3389/fnagi.2025.1604378. eCollection 2025.
3
Amyotrophic Lateral Sclerosis: Pathophysiological Mechanisms and Treatment Strategies (Part 2).
肌萎缩侧索硬化症:病理生理机制与治疗策略(第二部分)
Int J Mol Sci. 2025 May 29;26(11):5240. doi: 10.3390/ijms26115240.
4
Aspartate in the Brain: A Review.大脑中的天冬氨酸:综述
Neurochem Res. 2025 Jun 12;50(3):199. doi: 10.1007/s11064-025-04454-3.
5
Longitudinal assessment of cortical motor function in amyotrophic lateral sclerosis.肌萎缩侧索硬化症皮质运动功能的纵向评估
Sci Rep. 2025 May 15;15(1):16978. doi: 10.1038/s41598-025-01570-6.
6
Excitatory Amino Acid Transporters as Therapeutic Targets in the Treatment of Neurological Disorders: Their Roles and Therapeutic Prospects.兴奋性氨基酸转运体作为神经系统疾病治疗的靶点:它们的作用及治疗前景
Neurochem Res. 2025 Apr 29;50(3):155. doi: 10.1007/s11064-025-04400-3.
7
SARM1: The Checkpoint of Axonal Degeneration in the Nervous System Disorders.SARM1:神经系统疾病中轴突退化的检查点。
Mol Neurobiol. 2025 Mar 17. doi: 10.1007/s12035-025-04835-3.
8
Yin Yang 1: Function, Mechanisms, and Glia.阴阳1:功能、机制与神经胶质细胞
Neurochem Res. 2025 Feb 4;50(2):96. doi: 10.1007/s11064-025-04345-7.
9
Circulating GLAST EVs are increased in amyotrophic lateral sclerosis.在肌萎缩侧索硬化症中,循环中的谷氨酸天冬氨酸转运体(GLAST)细胞外囊泡会增加。
Front Mol Biosci. 2024 Nov 21;11:1507498. doi: 10.3389/fmolb.2024.1507498. eCollection 2024.
10
EAAT2 Activation Regulates Glutamate Excitotoxicity and Reduces Impulsivity in a Rodent Model of Parkinson's Disease.EAAT2激活调节谷氨酸兴奋性毒性并降低帕金森病啮齿动物模型中的冲动性。
Mol Neurobiol. 2025 May;62(5):5787-5803. doi: 10.1007/s12035-024-04644-0. Epub 2024 Dec 4.